Rhodes Jason P's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Apr 27, 2026
- Accession no.
- 0001577014-26-000004
- Filed
- Apr 27, 2026
- Trade date
- Apr 23-27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.10M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rhodes Jason PCIK 0001577014 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | SSaleDisposed | −19,261 | $19.19 | −$369,618.59 | 1,719,356 | Indirect | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −38,322 | $19.19 | −$735,399.18 | 5,221,857 | Indirect | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −377 | $19.19 | −$7,234.63 | 11,286 | Indirect | |
| Apr 23, 2026 | Common Stock | SSaleDisposed | −15,148 | $19.19 | −$290,690.12 | 1,270,556 | Indirect | |
| Apr 24, 2026 | Common Stock | SSaleDisposed | −36,345 | $18.48 | −$671,655.6 | 1,683,011 | Indirect | |
| Apr 24, 2026 | Common Stock | SSaleDisposed | −72,310 | $18.48 | −$1,336,288.8 | 5,149,547 | Indirect | |
| Apr 24, 2026 | Common Stock | SSaleDisposed | −710 | $18.48 | −$13,120.8 | 10,576 | Indirect | |
| Apr 24, 2026 | Common Stock | SSaleDisposed | −28,583 | $18.48 | −$528,213.84 | 1,241,973 | Indirect | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −45,709 | $18.15 | −$829,618.35 | 1,637,302 | Indirect | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −90,943 | $18.15 | −$1,650,615.45 | 5,058,604 | Indirect | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −894 | $18.15 | −$16,226.1 | 9,682 | Indirect | |
| Apr 27, 2026 | Common Stock | SSaleDisposed | −35,947 | $18.15 | −$652,438.05 | 1,206,026 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.